destroy The wave of lawsuits in the USA against the pharmaceutical and chemical company Bayer to the health hazards of the weeds TERS, glyphosate has increased, as expected, significantly. Up to 11. October were approximately 42’700 complaints delivered
This Bayer announced on Wednesday at the presentation of the business figures for the third quarter. The are more than twice as many complaints as the 18’400 by mid-July.
The action figure jumps since August of 2018 to the top. Bayer now has three process defeats the United States suffered, and had been sentenced in first instance to high penalties. Finally, the plaintiffs ‘ lawyers had advertised again for more clients. The pressure on Bayer to some, in comparison with the opposite side, is likely to increase.
The wave of lawsuits has been brought by Bayer with the billion-dollar Acquisition of the US seed giant Monsanto to glyphosate has developed. With the acquisition of the agricultural business increased significantly and Bayer, the world’s largest providers of seed and plant protection products.
results for course
For the year, goals the group is on course. Bayer benefited in the third quarter of the demand for drugs such as the anticoagulant Xarelto. Also the Agricultural business, in which the 2018 acquired the U.S. Seed company Monsanto rose to put. Group sales rose in the three months to end-September compared to the same period last year by 6.1 percent to 9,83 billion euros.
earnings before interest, taxes, depreciation and amortization (Ebitda) increased by 7.5 percent to EUR 2.3 billion. Both values were slightly above the average of analysts ‘ estimates.
The Surplus fell 64 percent, to around one billion euros. However, the sale of Parts of the seed business to BASF, the Dax had given group in the previous year, a special profits.
(oli/sda)
Created: 30.10.2019, 09:50 PM